This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Beltren - Teaching Note
Johnson, RobTeaching Note ET-21-EEntrepreneurship, Finance, Innovation and ChangeJean-Marc Chardon, of Sofina Ventures, considers alternative ways to structure a financing round by his venture capital firm in Beltren, which develops an innovative medical instrument used in spinal surgery.Starting at €0.00
-
Haier In Japan: An Ongoing Transformational Journey (Chinese Version)
Sánchez-Runde, Carlos; Lee, Yih-Teen; Reiche, SebastianCase DPO-464-ZHInnovation and Change, Leadership and People ManagementFor Du Jingguo, president of Haier Asia, a lot had been achieved since Haier acquired Sanyo in Japan. Compared with the beginning of 2012, the year of the acquisition, employees' morale had been restored. People were generally motivated and saw a positive future for the company and their own careers. A new organizational structure based on the principles of self-managed units (ZZJYT) and the Rendanheyi principle had been created. Some units even ...Starting at €8.20
-
Beltren
Johnson, RobCase E-143Entrepreneurship, Finance, Innovation and ChangeJean-Marc Chardon, de Sofina Ventures, se encontraba frente al ordenador buscando formas alternativas de estructurar una ronda de financiación por parte de su sociedad de capital riesgo en Beltren, una empresa que había desarrollado un instrumento médico innovador utilizado en cirugía espinal.Starting at €8.20
-
Beltren
Johnson, RobCase E-222-EEntrepreneurship, Finance, Innovation and ChangeJean-Mar Chardon, of Sofina Ventures, was at his computer, looking at alternative ways to structure financing round by his venture capital firm in Beltren, the developer of an innovative medical instrument used in spinal surgery. This case is based on the case E-143-E with the same title from the same author.Starting at €8.20
-
GeneRisk.com
Johnson, RobCase E-67Entrepreneurship, Innovation and ChangeA mediados del año 2000, los inversores en Medical Sciences Limited (MSL) consolidaron una nueva compañía, GeneRisk.com, para concentrar su capital en una herramienta de software propiedad de MSL. La inmediata cuestión planteada a los inversores de MSL fue cómo evaluar esta nueva compañía para la siguiente tanda de financiación.Starting at €8.20
-
GeneRisk.com
Johnson, RobCase E-67-EEntrepreneurship, Innovation and ChangeIn mid-2000 the investors in Medical Sciences Limited (MSL) set up a new company, GeneRisk.com, to capitalize on a proprietary software tool owned by MSL. The immediate issue facing MSL's investors was how to value this new company for the upcoming round of financing.Starting at €8.20
-
An Approach to Structuring Venture Investments
Claflin T. M.; Johnson, RobTechnical Note EN-7-EEntrepreneurship, Innovation and ChangeThe note describes a specific structure for financings for early-stage private companies.Starting at €8.20
-
Un enfoque sobre la estructuración de las inversiones de capital riesgo
Claflin T. M.; Johnson, RobTechnical Note EN-7Entrepreneurship, Innovation and ChangeEsta nota describe una estructura específica para la financiación de empresas privadas en fase inicial.Starting at €8.20
-
Haier In Japan: An Ongoing Transformational Journey
Sánchez-Runde, Carlos; Lee, Yih-Teen; Reiche, SebastianCase DPO-464-EInnovation and Change, Leadership and People ManagementFor Du Jingguo, president of Haier Asia, a lot had been achieved since Haier acquired Sanyo in Japan. Compared with the beginning of 2012, the year of the acquisition, employees' morale had been restored. People were generally motivated and saw a positive future for the company and their own careers. A new organizational structure based on the principles of self-managed units (ZZJYT) and the Rendanheyi principle had been created. Some units even ...Starting at €8.20
-
Assessing Non-US Markets for Private Equity Investments
Johnson, RobTechnical Note EN-6-EEntrepreneurship, Innovation and ChangeA model for evaluating the climate for venture capital and private equity investments in countries around the world.Starting at €8.20